COVID-19 Clinical Trials Report Card: Chloroquine and Hydroxychloroquine, CEBM
Chloroquine and hydroxychloroquine (CQ/HCQ) are antimalarial medications and are also used in the treatment of lupus erythematosus and rheumatoid arthritis. Both have been prominently touted as prospective candidates for the treatment and/or prevention of infection by SARS-Cov-2. This has led to an explosion of research into these treatments.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Arthritis | Clinical Trials | COVID-19 | Health | Hydroxychloroquine | Lupus | Rheumatoid Arthritis | Rheumatology | SARS